Emerging Research and News in Prostate Cancer Imaging — February 2025

News
Slideshow

Catch up on the most-well viewed prostate imaging content in February 2025.

Touching on a variety of topics in prostate cancer imaging, ranging from common contributing factors with false positives and false negatives on prostate MRI to a new meta-analysis on PET/CT radiotracers, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for February 2025.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Related Content
GE HealthCare Introduces Signa Sprint 1.5T MRI System at ISMRM Conference

GE HealthCare Introduces Signa Sprint 1.5T MRI System at ISMRM Conference

Jeff Hall
May 12th 2025
Article

The combination of high-performance gradient technology and AI tools with the Signa Sprint MRI reportedly facilitate enhanced MRI workflow efficiencies in cardiac and oncology imaging.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

What a New MRI Meta-Analysis Reveals About AI-Powered Hippocampal Segmentation and Alzheimer’s Disease

What a New MRI Meta-Analysis Reveals About AI-Powered Hippocampal Segmentation and Alzheimer’s Disease

Jeff Hall
May 8th 2025
Article

While AI-enabled hippocampal segmentation on MRI offered a 95 percent AUC for differentiating between Alzheimer’s disease and normal controls in a 27-study meta-analysis, it offered significantly lower sensitivity and specificity in differentiating mild cognitive impairment.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

MRI Study Shows Impact of Gross Total Resection on Survival of Patients with IDH Wild-Type Glioblastoma

MRI Study Shows Impact of Gross Total Resection on Survival of Patients with IDH Wild-Type Glioblastoma

Jeff Hall
May 7th 2025
Article

Irrespective of age or O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status, gross total resection of IDH wild-type glioblastomas was associated with a median overall survival of 32.6 months, according to new MRI research.

FDA Clears Dual-Head SPECT/CT System with Deep Learning Image Reconstruction

FDA Clears Dual-Head SPECT/CT System with Deep Learning Image Reconstruction

Jeff Hall
May 6th 2025
Article

The combination of the Aurora SPECT/CT system with AI-enabled Clarify DL image reconstruction reportedly offers the potential of enhanced image quality and streamlined workflows in nuclear medicine.

© 2025 MJH Life Sciences

All rights reserved.